Citation: Rja. Budde et al., Cloning, expression, purification and characterization of the alternate splice Src variants for drug discovery, J MOL CAT B, 11(4-6), 2001, pp. 805-809
Citation: Gq. Sun et Rja. Budde, Affinity purification of Csk protein tyrosine kinase based on its catalytic requirement for divalent metal cations, PROT EX PUR, 21(1), 2001, pp. 8-12
Authors:
Wang, W
Ramdas, L
Sun, GQ
Ke, S
Obeyesekere, NU
Budde, RJA
McMurray, JS
Citation: W. Wang et al., Cyclic peptides incorporating 4-carboxyphenylalanine and phosphotyrosine are potent inhibitors of pp60(c)-(src), BIOCHEM, 39(17), 2000, pp. 5221-5228
Authors:
Ramdas, L
Obeyesekere, NU
Sun, G
McMurray, JS
Budde, RJA
Citation: L. Ramdas et al., N-myristoylation of a peptide substrate for Src converts it into an apparent slow-binding bisubstrate-type inhibitor, J PEPT RES, 53(5), 1999, pp. 569-577
Citation: Gq. Sun et Rja. Budde, Substitution studies of the second divalent metal cation requirement of protein tyrosine kinase CSK, BIOCHEM, 38(17), 1999, pp. 5659-5665
Authors:
Ramdas, L
Bunnin, BA
Plunkett, MJ
Sun, GQ
Ellman, J
Gallick, G
Budde, RJA
Citation: L. Ramdas et al., Benzodiazepine compounds as inhibitors of the Src protein tyrosine kinase:Screening of a combinatorial library of 1,4-benzodiazepines, ARCH BIOCH, 368(2), 1999, pp. 394-400
Citation: Gq. Sun et Rja. Budde, Mutations in the N-terminal regulatory region reduce the catalytic activity of Csk, but do not affect its recognition of Src, ARCH BIOCH, 367(2), 1999, pp. 167-172